Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CAPERE Thrombectomy System

K-Number: K201216 · 2020-07-08

Decision Date2020-07-08
Product CodeQEW
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

CAPERE Thrombectomy System is a medical device manufactured by Vascular Medcure, Inc.. It received FDA 510(k) clearance on 2020-07-08 under approval number K201216. The device is classified under product code QEW. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CAPERE Thrombectomy System?

CAPERE Thrombectomy System is a medical device that received FDA 510(k) clearance on 2020-07-08. It is manufactured by Vascular Medcure, Inc.. The 510(k) number is K201216.

When was CAPERE Thrombectomy System approved by the FDA?

CAPERE Thrombectomy System received FDA 510(k) clearance on 2020-07-08, under approval number K201216.

What company makes CAPERE Thrombectomy System?

CAPERE Thrombectomy System is manufactured by Vascular Medcure, Inc..

What is the FDA product code for CAPERE Thrombectomy System?

The FDA product code for CAPERE Thrombectomy System is QEW.

Related Clinical Trials

Other Devices by Vascular Medcure, Inc.

Related Devices (Code: QEW)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.